GLP-1 Agonists Linked to Reduced Kidney Failure Risk in Obesity, CKD | Retatrutide News

GLP-1 receptor agonists may reduce kidney failure risk in obese patients with CKD, according to Pharmacy Times. The findings highlight potential renal b...
Clinical Trials · October 27, 2026